Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03771222
What this trial is testing

Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies

Who this might be right for
Donor Lymphocyte InfusionPeripheral Blood Stem Cell TransplantationRelapse+2 more
Chinese PLA General Hospital 40
Testing effectiveness (Phase 2)WithdrawnNCT01882387
What this trial is testing

Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Tarix Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Not applicableUnknownNCT03880214
What this trial is testing

Prevalence of Chronic Oral Graft Versus Host Disease Risk Factors in Pediatric Patients

Who this might be right for
Oral DiseaseGraft-versus-host-diseaseStem Cell Transplant Complications+1 more
yasmeen magdi sholkamy 250
Testing effectiveness (Phase 2)Study completedNCT00002833
What this trial is testing

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
M.D. Anderson Cancer Center 53
Early research (Phase 1)Study completedNCT04995653
What this trial is testing

A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Seres Therapeutics, Inc. 60
Early research (Phase 1)Study completedNCT00001748
What this trial is testing

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Who this might be right for
Graft vs Host DiseaseHematologic NeoplasmsLymphoma+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Testing effectiveness (Phase 2)Study completedNCT00003396
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819396
What this trial is testing

Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+11 more
Fred Hutchinson Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Not applicableLooking for participantsNCT04745221
What this trial is testing

Efficacy and Safety of Auto-FMT in Preventing aGVHD

Who this might be right for
Graft Versus Host Disease, Acute
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)WithdrawnNCT05509582
What this trial is testing

Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias

Who this might be right for
Immune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD
National Heart, Lung, and Blood Institute (NHLBI)
Large-scale testing (Phase 3)Study completedNCT00128739
What this trial is testing

Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation

Who this might be right for
Graft Vs Host Disease
Rafa Laboratories 24
Testing effectiveness (Phase 2)Ended earlyNCT02169505
What this trial is testing

Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Testing effectiveness (Phase 2)Looking for participantsNCT06299462
What this trial is testing

PTCy and ATG for MSD and MUD Transplants

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+2 more
Instituto Nacional de Cancer, Brazil 50
Not applicableUnknownNCT00017654
What this trial is testing

Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia

Who this might be right for
Graft Versus Host DiseaseAplastic Anemia
Northwestern Memorial Hospital 3
Testing effectiveness (Phase 2)Study completedNCT00886522
What this trial is testing

Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

Who this might be right for
Hematological Malignancies
IRCCS Azienda Ospedaliero-Universitaria di Bologna 23
Early research (Phase 1)Study completedNCT02728895
What this trial is testing

Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Takeda 24
Testing effectiveness (Phase 2)Study completedNCT01025778
What this trial is testing

Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Lund University Hospital 7
Next Page